How to deal with cycloserine resistance?

Cycloserine (Cycloserine) is an important drug in the treatment of multidrug-resistant tuberculosis (MDR-TB). It has significant efficacy, but long-term use may also cause drug resistance problems. This article will deeply explore the mechanism and causes of cycloserine resistance, and provide corresponding detection and evaluation methods, as well as effective strategies for dealing with resistance.

1. Analysis of the drug resistance mechanism of cycloserine

Cycloserine mainly competitively inhibits the key enzymes in bacterial cell wall synthesis-alanine lysinase and D-alanine-D-alanine synthase, thereby interfering with the synthesis of peptidoglycan and exerting anti-tuberculosis effects. However, bacteria can change the structure or function of these enzymes through mutation or gene expression regulation, reduce the inhibitory effect of cycloserine, and then develop drug resistance.

2. Multiple factors causing drug resistance

1.Irregular medication behavior: Patients who do not take medication as prescribed, miss doses, or stop medication without authorization will increase the risk of bacterial resistance. Irregular drug concentrations give bacteria a chance to survive in sub-inhibitory concentrations of antibiotics and acquire resistance through mutation.

2.Limitations of single drug treatment: When cycloserine is used alone, it is more likely to lead to drug resistance. Multidrug combination therapy can inhibit bacterial growth through multiple mechanisms, thereby reducing the possibility of drug resistance.

3.The impact of individual differences among patients: The patient’s metabolic level, immune status and other factors will also affect the efficacy of antibiotics and the risk of drug resistance.

4.The role of bacterial genetic variation: Mycobacterium tuberculosis has a high mutation rate, and strains resistant to cycloserine can be produced through random mutations.

3. Methods for detection and assessment of drug resistance

When treatment is found to be ineffective or drug resistance is suspected, drug susceptibility testing is a critical step in confirming drug resistance. Drug susceptibility testing can detect the sensitivity of bacteria to cycloserine and other anti-tuberculosis drugs and guide clinicians to adjust treatment plans. Specific methods include:

1.Molecular biology testing: PCR and other molecular biology techniques are used to detect specific mutations in the genes of Mycobacterium tuberculosis, which are associated with drug resistance.

2.Traditional culture method: Culture the patient's sputum samples and observe the growth of bacteria in media containing different concentrations of cycloserine to determine drug resistance.

4. Effective Strategies for Treating Drug Resistance

1.Drug adjustment: When the drug susceptibility test results show resistance to cycloserine, use should be stopped immediately, and other effective anti-tuberculosis drugs, such as fluoroquinolones, aminoglycosides, etc., should be selected based on the drug susceptibility test results.

2.The importance of combination therapy: A multi-drug combination therapy should be used to inhibit the growth of Mycobacterium tuberculosis with multiple mechanisms working together. WHOrecommended MDR-TB treatment regimens usually include at least five drugs.

3. Close monitoring and treatment adjustment: Regular follow-up and drug sensitivity testing should be conducted during the treatment process to monitor treatment effects and changes in drug resistance, and adjust treatment plans in a timely manner.

4.Patient education and compliance improvement: Improve patients’ awareness of drug resistance issues, ensure that they take medications in strict accordance with the doctor’s instructions, and understand the risks of not taking medications on time or stopping medications without authorization.

5.Exploration of innovative treatment methods: Treatment options that combine new drugs such as bedaquiline and delamanid may provide new treatment options for patients with drug-resistant tuberculosis.

In summary, cycloserine plays an important role in the treatment of tuberculosis, especially multidrug-resistant tuberculosis, but its drug resistance problem cannot be ignored. By standardizing medication use, close monitoring, scientifically adjusting treatment plans, and strengthening international cooperation and innovative research, we can effectively deal with cycloserine resistance and improve the cure rate of tuberculosis.